Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Endo Health
Personalized “AI endocrinologist” for type 2 diabetes
TL;DR
What they do: AI-driven consumer health platform focused on metabolic disease management (weight loss, diabetes/pre-diabetes) using CGM and conversational coaching
HQ & founded: San Francisco; founded 2024
Early investors: General Catalyst, a16z Speedrun, Anne Wojcicki, Krew Capital
Company stage / funding: Multiple early-stage rounds in 2024; total funding reported $1,000,000 (USD)
Team size (public): Approximately 4 employees
Company Overview
Problem Domain
Metabolic disease management (weight loss, diabetes / pre-diabetes)
Founded
2024
Industry
Digital health / consumer health
Funding Track Record
Dealroom lists a Feb 2024 entry associated with Krew Capital
Dealroom/Czech profiles list an entry in Jun 2024 involving a16z Speedrun
1000000.00 USD
Public profiles indicate General Catalyst as a lead/recent investor with a 2024 round; total funding reported $1,000,000
Investor Signal
“Backed by prominent investors including General Catalyst, a16z Speedrun, Anne Wojcicki, and Krew Capital”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week